Summary
This prediction ended on 23.03.17 with a price of €54.12. With a performance of 37.77% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novan Inc | - | - | - | - |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% | 54.489% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% | 85.552% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% | 55.407% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% | 62.988% |
Comments by melinda for this prediction
In the thread Novan Inc diskutieren
folgen
Phase 3 High-End - Daten aufgrund 1Q 2017.
SB204
Akne vulgaris
Urtext
Phase 3 Top-Line-Daten aufgrund 1Q 2017.
Eine bessere Übersetzung vorschlagen
(Vom Mitglied beendet)